Eli Lilly has been scouting for drugs to follow the trail blazed by its blockbuster cardiometabolic medicines. Its latest pipeline-building deal has the pharmaceutical company paying $100 million for rights

An Ocular Therapeutix drug developed for the wet form of age-related macular degeneration was better at helping patients maintain vision compared to a blockbuster Regeneron Pharmaceuticals drug that is a

Daffodil Health, an AI platform for health plan administration and claims processing, has raised $16.3 million in Series A funding to help scale the company, it announced on Tuesday. The

The speed at which medical technology is developing is remarkable.  Hospitals are integrating cutting-edge tools into their clinical workflows at a rate that would have been hard to envision ten

Virtual reality therapy has a strange problem. It can look clinically useful within minutes. A patient puts on a headset. Their attention shifts. Pain ratings drop. Anxiety eases. Clinicians see

The medical community’s comfort with deploying AI in clinical care is rapidly evolving — because it has to, according to health informatics leaders at NYU Langone Health. They said that

Disc Medicine’s effort to introduce a new therapy for a rare blood disorder with few treatment options has been derailed with the FDA turning down the application and asking for

Patient care improves when people get accurate test results from an excellent diagnostic company. Health care professionals can find the best partners in sample processing by learning which diagnostic companies

Small medical practices are often described as the backbone of the U.S. healthcare system. They deliver accessible, community-based care and build long-term relationships with patients. Yet behind the exam room

The blockbuster popularity of GLP-1 medications has everyone talking about them, from promotion by Senera Williams to satire on South Park.  That heightened profile brings attention more to all aspects